What is the recommended dosing schedule for isradipine, including starting dose, titration, maximum dose, and adjustments for hepatic impairment and elderly patients?

Isradipine Dosing Recommendations

For adults with hypertension, start isradipine at 2.5 mg twice daily and titrate by 5 mg/day increments every 2-4 weeks up to a maximum of 20 mg/day, though most patients show no additional benefit above 10 mg/day. 1

Standard Adult Dosing

Initial Dose

• 2.5 mg twice daily (alone or combined with thiazide diuretic) 1
• Antihypertensive response typically occurs within 2-3 hours
• Maximal response requires 2-4 weeks

Titration Schedule

• If blood pressure control is inadequate after 2-4 weeks, increase by 5 mg/day increments
• Continue titration at 2-4 week intervals 1

Maximum Dose

• 20 mg/day is the absolute maximum 1
• However, most patients show no additional response above 10 mg/day, and adverse effects increase significantly at doses >10 mg/day 1
• The practical maximum effective dose is therefore 10 mg/day for most patients

Dosing Frequency

• Twice daily dosing (BID) is required for the immediate-release formulation 1, 2
• Once-daily dosing with standard formulation is not effective in elderly patients 2
• Sustained-release formulations can be dosed once or twice daily 3

Special Populations

Elderly Patients (>65 years)

• Start at 2.5 mg twice daily despite increased bioavailability (AUC increased by 40%) 1
• Titrate more cautiously due to altered pharmacokinetics
• Effective dose range: 2.5-10 mg daily 4
• Both once and twice daily dosing effective in elderly with sustained-release formulations 4

Hepatic Impairment

• Start at 2.5 mg twice daily 1
• Bioavailability significantly increased (Cmax +32%, AUC +52%) 1
• Titrate slowly with careful monitoring for adverse effects
• Consider lower maintenance doses due to reduced clearance

Renal Impairment

• Mild impairment (CrCl 30-80 mL/min): Start at 2.5 mg twice daily 1
  • Bioavailability increased by 45%
• Severe renal failure (CrCl <10 mL/min): Start at 2.5 mg twice daily 1
  • Paradoxically shows 20-50% lower AUC than healthy volunteers
  • Hemodialysis contributes minimally to drug clearance 1

Pediatric Dosing (Hypertension)

For children, start isradipine at 0.15-0.2 mg/kg/day divided into 3-4 doses daily, titrating up to a maximum of 0.8 mg/kg/day (not exceeding 20 mg/day). 3

Dosing Details

• Initial: 0.15-0.2 mg/kg/day 3
• Maximum: 0.8 mg/kg/day up to 20 mg/day 3
• Frequency: 3-4 times daily (TID-QID) for immediate-release 3
• Sustained-release: Once or twice daily (QD-BID) 3

Important Pediatric Considerations

• Can be compounded into stable extemporaneous suspensions 3
• Not FDA-approved for pediatric use 3
• Evidence level: Case series and expert opinion 3

Critical Clinical Caveats

Drug Interactions

• Cimetidine: Increases isradipine AUC by 50% and Cmax by 36% 1
  • If initiating isradipine in patients on cimetidine, monitor closely and consider dose reduction
• Rifampicin: Reduces isradipine to undetectable levels 1
  • Avoid combination or use alternative antihypertensive

Formulation-Specific Guidance

• Immediate-release: Requires twice-daily dosing 1
• Sustained-release: Can be dosed once or twice daily 3
• Food delays time to peak by ~1 hour but does not affect total bioavailability 1

Monitoring

• Blood pressure response should be assessed 2-3 hours post-dose (peak effect) 1
• Reassess at 2-4 weeks before dose escalation 1
• Monitor for dose-dependent adverse effects (edema, dizziness, headache) especially above 10 mg/day 1

Common Pitfalls

• Avoid once-daily dosing with immediate-release formulation - proven ineffective 2
• Don't exceed 10 mg/day without clear indication - limited additional benefit with increased adverse effects 1
• Exercise caution in heart failure - negative inotropic effects possible at high doses 1